Evaluating reversible inhibitory drug–drug interactions: enzyme kinetics, and <i>in vitro</i>-to-<i>in vivo</i> scaling models
Analysis based on the equation shows that, for inhibitors with the same inhibition constant (Ki), competitive inhibitors will pose a higher potential for DDIs compared to non-competitive inhibitors, while complete inhibitors will result in a higher potential for DDI than partial inhibitors.
Authors
- Philip W Melchert (ORCID: https://orcid.org/0000-0001-8276-6621)
- John S. Markowitz (ORCID: https://orcid.org/0000-0002-9830-5392)
- Qingchen Zhang (ORCID: https://orcid.org/0009-0006-8919-7429)
- David J. Greenblatt
Institutions
- Tufts University (US)
- University of Florida (US)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1093/jpp/rgaf029
- Citations
- 3
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 4.51